Activist Investors are Betting on Allscripts Healthcare Solutions Inc. (MDRX)

Activist investors Ricky Sandler of Eminence Capital and Clifton S. Robbins of Blue Harbour Group increased their stakes in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) during the fourth quarter of 2013, controlling 4.8% and 4.5%, respectively, of the healthcare technology company at the end of the year.

Ricky Sandler

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) is a $3.3 billion market capitalization company that provides clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations (such as nursing homes). In addition to its core electronic health records (EHR) solutions, the company has been generating strong growth with its population health management product, which aggregates and analyzes patient medical data to better manage and improve their outcomes.

The company has been trying to turn around its operations after a dismal 2012, when the stock took a dive due to deteriorating financial performance. Following pressure from hedge fund manager Arthur Cohen of HealthCor Management (who is currently the third largest shareholder), several members of its management team and board left that year. Allscripts Healthcare Solutions had also reviewed strategic options, including a possible sale, but in late 2012 decided, it would be best to continue operating as an independent company under new management.

More recently, Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)’s results have been on the mend, as its turnaround plans have resulted in strong bookings, improving earnings and a higher stock price (which increased 64% in 2013 and another 21% so far in 2014). For the next three years, management expects revenue growth of 5-8% (as bookings recorded thus far convert to revenue in subsequent years), modest improvement in gross margins, flat spending and higher yields related to research and development, and a decline in selling, general and administrative expenses in 2014 (versus 2013) and steady expenses thereafter. These should all translate into EBITDA growth of 18-22% and improved free cash flows over the near-to-intermediate term.

On a forward EV/EBITDA basis, Allscripts’ multiple of 16.5X is in-line with its peer group of healthcare technology companies. At the same time, the company’s debt burden is higher, with a debt / capital ratio of 29.9% (versus 8.4% for peers), an interest expense coverage ratio (EBITDA / interest expense) of 1.1X (versus 5.2X for peers) and a net debt / EBITDA of 16.2X (versus 6.1X for peers). Given the expected improvements in its earnings over the next three years, these metrics should improve over time. Its near-term debt maturities are limited, with only $17 million coming due in 2014, which should also provide a cushion to its balance sheet.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX)’s progress on delivering its intermediate goals will be key for the stock to maintain its momentum. Management is well aware of the three activist investors with large stakes in the company. Should the company’s financial performance deviate from plan, we would not be surprised if either Eminence Capital or Blue Harbour Group – its seventh and eighth largest shareholders, respectively – file 13D filings disclosing an increase in their stakes above the 5% threshold along with their plans to improve shareholder value.

Disclosure: none

Recommended Reading:

Healthcor Management Reduces Position in Allscripts Healthcare Solutions Inc (MDRX)

Allscripts Healthcare Solutions Inc (MDRX), Google Inc (GOOG): Will Augmented Reality Medical Apps Bridge a Gap in Health Care?

Healthcor Management Further Invests in CareView Communications Inc (CRVW)

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!